Preserved Cardiac Function despite Marked Impairment of cAMP Generation

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Gao, Mei Hua ^a   Lai, Ngai Chin ^a   Tang, Tong ^a   Guo, Tracy ^a   Tang, Ruoying ^a   Chun, Byeong Jo ^a   Wang, Hong ^a   Dalton, Nancy N ^a   Suarez, Jorge ^a   Dillmann, Wolfgang H ^a   Hammond, H Kirk ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CALCIUM; CYCLIC AMP; ISOPRENALINE; PHOSPHOLAMBAN; PROTEIN S 100; PROTEIN S 100A1; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG; ADENYLYL CYCLASE 6; CALCIUM BINDING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; PHOSPHODIESTERASE III; RYANODINE RECEPTOR; TRANSCRIPTION FACTOR; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CELL ISOLATION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE SIZE; HEART MUSCLE CELL; HEART PRESERVATION; INOTROPISM; ISOLATED HEART; MEDIAN EFFECTIVE CONCENTRATION; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SARCOPLASMIC RETICULUM; TRANSGENIC MOUSE; ANIMAL; BIOSYNTHESIS; CALCIUM SIGNALING; DRUG EFFECTS; ECHOCARDIOGRAPHY; GENE EXPRESSION; GENETICS; HEART; HEART CONTRACTION; HEART MUSCLE; HEART VENTRICLE; INTRACELLULAR SPACE; METABOLISM; MUTATION; PATHOPHYSIOLOGY; PHOSPHORYLATION; PROTEIN TRANSPORT;

ADENYLATE CYCLASE; ANIMALS; CALCIUM; CALCIUM SIGNALING; CALCIUM-BINDING PROTEINS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; ECHOCARDIOGRAPHY; GENE EXPRESSION; HEART; HEART VENTRICLES; INTRACELLULAR SPACE; ISOPROTERENOL; MICE; MICE, TRANSGENIC; MUTATION; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTEIN TRANSPORT; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TRANSCRIPTION FACTORS; TROPONIN I;

EID: 84884191374     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072151     Document Type: Article

References (30)

1. Cleland JG, Teerlink JR, Senior R, Nifontov EM, Mc Murray JJ, et al. (2011) The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. Lancet 378: 676-683.
2. Gao MH, Tang T, Guo T, Sun SQ, Feramisco JR, et al. (2004) Adenylyl cyclase type VI gene transfer reduces phospholamban expression in cardiac myocytes via activating transcription factor 3. J Biol Chem 279: 38797-3802.
3. Gao MH, Tang T, Guo T, Yajima T, Pestonjamasp K, et al. (2008) Adenylyl cyclase type VI increases Akt activity and phospholamban phosphorylation in cardiac myocytes. J Biol Chem 283: 33527-33535.
4. Gao MH, Tang T, Lai NC, Yajima T, Miyanohara A, et al. (2011) Beneficial effects of adenylyl cyclase type 6 (AC6) expression persist using a catalytically inactive AC6 mutant. Mol Pharmacol 79: 381-388.
5. Tang T, Gao MH, Lai NC, Firth AL, Takahashi T, et al. (2008) Adenylyl cyclase type 6 deletion decreases left ventricular function via impaired calcium handling. Circulation 117: 61-69.
6. Ping P, Anzai T, Gao MH, Hammond HK, (1996) Adenylyl cyclase and G protein receptor kinase expression during development of heart failure. Am J Physiol Heart Circ Physiol 273: H707-717.
7. Roth DM, Bayat H, Drumm JD, Gao MH, Swaney JS, et al. (2002) Adenylyl cyclase increases survival in cardiomyopathy. Circulation 105: 1989-1994.
8. Takahashi T, Tang T, Lai NC, Roth DM, Rebolledo B, et al. (2006) Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction. Circulation 114: 388-396.
9. Lai NC, Roth DM, Gao MH, Tang T, Dalton N, et al. (2004) Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure. Circulation 110: 330-336.
10. Roth DM, Gao MH, Lai NC, Drumm J, Dalton N, et al. (1999) Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy. Circulation 99: 3099-3102.
11. Lai NC, Tang T, Gao MH, Saito M, Takahashi T, et al. (2008) Activation of cardiac adenylyl cyclase expression increases function of the failing ischemic heart in mice. J Am Coll Cardiol 51: 1490-1497.
12. Tang T, Gao MH, Roth DM, Guo T, Hammond HK, (2004) Adenylyl cyclase type VI corrects cardiac sarcoplasmic reticulum calcium uptake defects in cardiomyopathy. Am J Physiol 287: H1906-1912.
13. Gaudin C, Ishikawa Y, Wight DC, Mahdavi V, Nadal-Ginard B, et al. (1995) Overexpression of Gsα protein in the hearts of transgenic mice. J Clin Invest 95: 1676-1683.
14. Engelhardt S, Hein L, Wiesmann F, Lohse MJ, (1999) Progressive hypertrophy and heart failure in β1-adrenergic receptor transgenic mice. Proc Natl Acad Sci 96: 7059-7064.
15. Liggett SB, Tepe NM, Lorenz JN, Canning AM, Jantz TD, et al. (2000) Early and delayed consequences of β2-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation 101: 1707-1714.
16. Antos CL, Frey N, Marx SO, Reiken S, Gaburjakova M, et al. (2001) Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase A. Circ Res 89: 997-1004.
17. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, Dibianco R, et al. (1991) Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 325: 1468-1475.
18. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, et al. (1982) Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 307: 205-211.
19. Suarez J, Scott B, Dillmann WH, (2008) Conditional increase in SERCA2a protein is able to reverse contractile dysfunction and abnormal calcium flux in established diabetic cardiomyopathy. Am J Physiol 295: R1439-1445.
20. Brittsan AG, Kranias EG, (2000) Phospholamban and cardiac contractile function. J Mol Cell Cardiol 32: 2131-2139.
21. Chu G, Lester JW, Young KB, Luo W, Zhai J, et al. (2000) A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta-agonists. J Biol Chem 275: 38938-38943.
22. Luo W, Chu G, Sato Y, Zhou Z, Kadambi VJ, et al. (1998) Transgenic approaches to define the functional role of dual site phospholamban phosphorylation. J Biol Chem 273: 4734-4739.
23. Foulkes NS, Borrelli E, Sassone-Corsi P, (1991) CREM gene: use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription. Cell 64: 739-749.
24. Most P, Remppis A, Pleger ST, Löffler E, Ehlermann P, et al. (2003) Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance. J Biol Chem 278: 33809-33817.
25. Mayr B, Montminy M, (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2: 599-609.
26. Song W, Zimmer DB, (1996) Expression of the rat S100A1 gene in neurons, glia, and skeletal muscle. Brain Res 721: 204-216.
27. Iancu RV, Ramamurthy G, Harvey RD, (2008) Spatial and temporal aspects of cAMP signaling in cardiac myocytes. Clin Exp Pharmacol Physiol 35: 1343-1348.
28. Efendiev R, Samelson BK, Nguyen BT, Phatarpekar PV, Baameur F, et al. (2010) AKAP79 interacts with multiple adenylyl cyclase (AC) isoforms and scaffolds AC5 and AC6 to α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptors. J Biol Chem 285: 14450-14458.
29. Ostrom RS, Post SR, Insel PA, (2000) Stoichiometry and compartmentation in G protein-coupled receptor signaling: implications for therapeutic interventions involving Gs. J Pharmacol Exp Ther 294: 407-412.
30. Gao MH, Lai NC, Roth DM, Zhou J, Zhu J, et al. (1999) Adenylylcyclase increases responsiveness to catecholamine stimulation in transgenic mice. Circulation 99: 1618-1622.